Article Text

PDF
Vitamin D3 as a potentially modifiable factor in mild cognitive impairment
  1. Hiroshige Fujishiro
  1. Department of Psychiatry, Kawasaki Memorial Hospital, Kawasaki, Japan
  1. Correspondence to Dr Hiroshige Fujishiro, Department of Psychiatry, Kawasaki Memorial Hospital, Kawasaki, Japan; fujishiro17{at}hotmail.co.jp

Statistics from Altmetric.com

More biomarker-based research is required to determine the effectiveness of interventions in subjects with mild cognitive impairment (MCI)

MCI is a clinical diagnostic term for elderly subjects with impaired cognitive performance that does not significantly interfere with independent living. MCI, an intermediate condition between normal cognition and dementia, is typically divided into amnestic or non-amnestic subtypes, with single-domain or multidomain distinctions. After the diagnosis, some subjects with MCI develop Alzheimer’s disease (AD) dementia or other dementias resulting from non-AD brain diseases, whereas a substantial proportion of subjects may later be diagnosed as cognitively normal or remain diagnosed with MCI even after a prolonged period. Although the reason for the various clinical courses in subjects with MCI remains unclear, a recent large clinicopathological longitudinal study revealed disease …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles